MX342808B - Antibioticos de glicopeptidos. - Google Patents

Antibioticos de glicopeptidos.

Info

Publication number
MX342808B
MX342808B MX2012003238A MX2012003238A MX342808B MX 342808 B MX342808 B MX 342808B MX 2012003238 A MX2012003238 A MX 2012003238A MX 2012003238 A MX2012003238 A MX 2012003238A MX 342808 B MX342808 B MX 342808B
Authority
MX
Mexico
Prior art keywords
glycopeptide antibiotics
compounds
glycopeptide
antibiotics
useful
Prior art date
Application number
MX2012003238A
Other languages
English (en)
Inventor
Arnold Lotvin Jason
Robert Abbanat Darren
Sue Bernan Valerie
Greenstein Michael
He Haiyin
Gordon Sutherland Alan
Edward Ruppen Mark
Emery Bailey Arthur
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX342808B publication Critical patent/MX342808B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de la fórmula (I) (ver fórmula (I)) en donde R1, R2, R3, R4, R5, R6a, R6b, R6C, R6d, R6e y R7 se definen en la especificación. Estos compuestos son útiles como agentes antibióticos.
MX2012003238A 2001-04-25 2002-04-25 Antibioticos de glicopeptidos. MX342808B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28639601P 2001-04-25 2001-04-25
PCT/US2002/013108 WO2002086141A1 (en) 2001-04-25 2002-04-25 Glycopeptide antibiotics

Publications (1)

Publication Number Publication Date
MX342808B true MX342808B (es) 2016-10-13

Family

ID=23098425

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012003238A MX342808B (es) 2001-04-25 2002-04-25 Antibioticos de glicopeptidos.
MXPA03009803A MXPA03009803A (es) 2001-04-25 2002-04-25 Antibioticos de glicopeptidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MXPA03009803A MXPA03009803A (es) 2001-04-25 2002-04-25 Antibioticos de glicopeptidos.

Country Status (7)

Country Link
EP (2) EP2270192A1 (es)
AT (1) ATE478155T1 (es)
CA (1) CA2445216C (es)
DE (1) DE60237360D1 (es)
ES (1) ES2348976T3 (es)
MX (2) MX342808B (es)
WO (1) WO2002086141A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109652483B (zh) * 2018-12-03 2022-07-29 曲阜师范大学 一种海洋放线菌液体发酵产物提取复合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3495004A (en) 1968-08-13 1970-02-10 American Cyanamid Co Antibiotic ac-98 and production thereof
DE60235538D1 (de) * 2001-04-25 2010-04-15 Wyeth Corp Glycopeptid-antibiotika
MXPA03009718A (es) * 2001-04-25 2004-01-29 Wyeth Corp Antibioticos glicopeptidicos ac-98-1; ac-98-2; ac-98-3; ac-98-4 y ac-98-5 substancialmente puros.

Also Published As

Publication number Publication date
CA2445216A1 (en) 2002-10-31
WO2002086141A1 (en) 2002-10-31
EP1390521A1 (en) 2004-02-25
CA2445216C (en) 2014-08-19
EP1390521B1 (en) 2010-08-18
MXPA03009803A (es) 2004-01-29
DE60237360D1 (en) 2010-09-30
EP1390521A4 (en) 2006-11-15
ATE478155T1 (de) 2010-09-15
EP2270192A1 (en) 2011-01-05
ES2348976T3 (es) 2010-12-20

Similar Documents

Publication Publication Date Title
GB0125222D0 (en) Composition for the treatment of microbial infections
IL140093A0 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
MY129319A (en) Crystal forms of azithromycin
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
PT1671949E (pt) Piridinilaminas substituídas
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
MY138285A (en) Fab i inhibitors
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
GB0114185D0 (en) Compounds
AU4652000A (en) Fab i inhibitors
AU2003290592A1 (en) Antitumor benzoylsulfonamides
UA83266C2 (en) Oxazole derivatives of tetracyclines
AU6279500A (en) Epothilone compositions
AU2881399A (en) N1-modified glycopeptides
MX342808B (es) Antibioticos de glicopeptidos.
EP1390056A4 (en) Glycopeptide antibiotics
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
AU2001258675A1 (en) Treating infections
GB0322750D0 (en) Organic compounds
MXPA03009718A (es) Antibioticos glicopeptidicos ac-98-1; ac-98-2; ac-98-3; ac-98-4 y ac-98-5 substancialmente puros.
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
AU1783700A (en) 1,8-benzonaphthyridine derivatives
AU2002366563A1 (en) Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders
CA2536501A1 (en) Crystal forms of azithromycin